Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Rectal cancers: Positioning of watchful waiting and minimally invasive procedures

Prof Henk Wegstapel - Canterbury Christ Church University, Canterbury, UK
Rectal cancers: Positioning of watchful waiting and minimally invasive procedures ( Prof Henk Wegstapel - Canterbury Christ Church University, Canterbury, UK )
9 May 2019

Using genetic testing to tailor chemotherapy

Prof Heinz-Josef Lenz - USC Norris Comprehensive Cancer Center, Los Angeles, USA
Using genetic testing to tailor chemotherapy ( Prof Heinz-Josef Lenz - USC Norris Comprehensive Cancer Center, Los Angeles, USA )
9 May 2019

Highlights from IGILUC 2019

Prof Hesham El-Ghazaly - Ain Shams University, Cairo, Egypt
Highlights from IGILUC 2019 ( Prof Hesham El-Ghazaly - Ain Shams University, Cairo, Egypt )
8 May 2019

ALK-positive NSCLC: Treatments and latest developments

Prof Tony Mok - Chinese University of Hong Kong, Hong Kong
ALK-positive NSCLC: Treatments and latest developments ( Prof Tony Mok - Chinese University of Hong Kong, Hong Kong )
29 Apr 2019

ALK-positive NSCLC: Current landscape

Dr Antonio Passaro and Prof Rafal Dziadziuszko
ALK-positive NSCLC: Current landscape ( Dr Antonio Passaro and Prof Rafal Dziadziuszko )
29 Apr 2019

How the WIN consortium achieves its goals

Prof Apostolia-Maria Tsimberidou - MD Anderson Cancer Centre, Houston, USA
How the WIN consortium achieves its goals ( Prof Apostolia-Maria Tsimberidou - MD Anderson Cancer Centre, Houston, USA )
25 Apr 2019

The translational element of the WIN consortium

Dr Brian Leyland-Jones - WIN Head of Fundraising Committee
The translational element of the WIN consortium ( Dr Brian Leyland-Jones - WIN Head of Fundraising Committee )
25 Apr 2019

Making oncology global with the WIN consortium

Dr Josep Tabernero - Vall d'Hebron Institute of Oncology, Barcelona, Spain
Making oncology global with the WIN consortium ( Dr Josep Tabernero - Vall d'Hebron Institute of Oncology, Barcelona, Spain )
25 Apr 2019

An overview of the WIN consortium

Dr Richard Schilsky - Chief Medical Officer, American Society of Clinical Oncology, USA
An overview of the WIN consortium ( Dr Richard Schilsky - Chief Medical Officer, American Society of Clinical Oncology, USA )
25 Apr 2019

The WIN symposium 2019

Prof Razelle Kurzrock - University of California San Diego, San Diego, USA
The WIN symposium 2019 ( Prof Razelle Kurzrock - University of California San Diego, San Diego, USA )
25 Apr 2019

Latest data from KEYNOTE 42: Pembrolizumab vs chemotherapy in treatment-naive patients (pts) with PD-L1 advanced NSCLC

Prof Tony Mok - Chinese University of Hong Kong, Hong Kong
Latest data from KEYNOTE 42: Pembrolizumab vs chemotherapy in treatment-naive patients (pts) with PD-L1  advanced NSCLC ( Prof Tony Mok - Chinese University of Hong Kong, Hong Kong )
18 Apr 2019

The role of afatinib in patients with EGFR NSCLC

Dr Antonio Passaro - European Institute of Oncology, Milan, Italy
The role of afatinib in patients with EGFR  NSCLC ( Dr Antonio Passaro - European Institute of Oncology, Milan, Italy )
18 Apr 2019